Novavax Nuvaxovid COVID vaccine approved in Canada for use as primary series in adolescents Ruchika Sharma8 Dec 2022 4:45 AM GMTGaithersburg: Novavax, Inc. has announced that Health Canada has approved a supplement to a New Drug Submission (sNDS) for Nuvaxovid (COVID-19 Vaccine...
Novavax seeks updated Emergency Use Listing from WHO for Nuvaxovid as booster in adults Ruchika Sharma18 Sep 2022 7:00 AM GMTUS: Novavax has announced the submission of a request to the World Health Organization (WHO) to update the Emergency Use Listing (EUL) of Nuvaxovid...
Novavax Nuvaxovid gets expanded conditional marketing authorization in EU for use as booster for adults aged 18 and older Ruchika Sharma14 Sep 2022 7:45 AM GMTGaithersburg: Biotechnology company, Novavax, Inc., has recently announced that the European Commission (EC) has approved the expanded conditional...
Novavax COVID vaccine Nuvaxovid gets expanded conditional marketing nod in UK for adolescents aged 12 through 17 Ruchika Sharma27 Aug 2022 5:45 AM GMTGaithersburg: Novavax, Inc. has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted...
Novavax COVID vaccine Nuvaxovid gets provisional nod in New Zealand for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 8:15 AM GMTNuvaxovid (NVX-CoV2373) is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes...
Novavax COVID jab shows high levels of protection against infection in two large phase-3 trials Ruchika Sharma18 Aug 2022 8:59 AM GMTDr Glenn further said the study was conducted with a vaccine based on the original Wuhan spike protein sequence.
Novavax COVID shot Nuvaxovid must carry warning of heart inflammation, recommends EU Ruchika Sharma4 Aug 2022 7:29 AM GMT"We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S....
COVID vaccine: Novavax requests WHO to expand Emergency Use Listing of Nuvaxovid for adolescents aged 12 through 17 Ruchika Sharma1 Aug 2022 9:55 AM GMTThe WHO previously granted EUL for Nuvaxovid in adults aged 18 and older in December 2021.
Novavax COVID vaccine Nuvaxovid gets European Commission conditional nod for adolescents Ruchika Sharma6 July 2022 6:06 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 7:00 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax COVID vaccine gets emergency use nod in Taiwan for adults Ruchika Sharma24 Jun 2022 6:03 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 5:30 AM GMTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
